TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Life Science Byrån LSB AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,624
|
1,469
|
1,425 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
593
|
437
|
518 |
| EBITDA |
579
|
426
|
518 |
| Total assets |
1,655
|
1,467
|
1,343 |
| Current assets |
1,120
|
1,163
|
1,173 |
| Current liabilities |
194
|
207
|
204 |
| Equity capital |
1,388
|
1,188
|
1,072 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
83.9%
|
81.0%
|
79.8% |
| Turnover per employee |
1,624
|
1,469
|
1,425 |
| Profit as a percentage of turnover |
36.5%
|
29.7%
|
36.4% |
| Return on assets (ROA) |
35.8%
|
29.8%
|
38.6% |
| Current ratio |
577.3%
|
561.8%
|
575.0% |
| Return on equity (ROE) |
42.7%
|
36.8%
|
48.3% |
| Change turnover |
129
|
-58
|
11 |
| Change turnover % |
9%
|
-4%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.